We provide scientific and subject matter expertise to expand and accelerate the delivery of high-quality clinical diagnostic products.
MRIGlobal offers government and commercial clients services that include assay design, assay development, analytical verification, and clinical validation through regulatory submission. We provide extensive research and product development expertise; facilities, analytical services, clinical trial site, and clinical trial services and support; and regulatory guidance to support FDA, EUA, and 510(k) submission filings.
MRIGlobal manages a variety of diagnostics programs.
Our capabilities range from the development of cutting-edge molecular and immunological assays focused on emerging highly infectious disease to the advancement of novel, highly sensitive diagnostic assays.
We offer a broad range of research and clinical laboratory services to accelerate product development and reduce time to market.
MRIGlobal has dedicated, experienced staff with expertise in molecular biology, immunology, microbiology, bioinformatics, and engineering. This includes staff expertise in diagnostic development, clinical regulatory affairs, quality management systems, and program management. Our culture of trust and integrity, in partnership with our clients, solves complex problems to help create a safer, healthier, more sustainable world.